Return to Contents in this Issue

Case Report


Desensitization to Co-trimoxazole in a Patient With Fixed Drug Eruption


G Patriarca, D Schiavino, A Buonomo, A Aruanno, G Altomonte, E Nucera

Department of Allergology, Università Cattolica del Sacro Cuore, Rome, Italy

J Investig Allergol Clin Immunol 2008; Vol. 18(4): 309-311



Although co-trimoxazole is a major cause of fixed drug eruption, there are no reports in the literature of desensitization protocols for co-trimoxazole in such patients. We present the case of an 85-year-old woman with a fixed drug eruption to co-trimoxazole. Since she
needed co-trimoxazole therapy for treatment of infection of a prosthetic hip by Staphylococcus aureus, she underwent allergy testing with
co-trimoxazole and its components sulfamethoxazole and trimethoprim. Allergy tests were all negative and a diagnosis of nonallergic hypersensitivity reaction to co-trimoxazole was made. Based on previous experience, we decided to attempt a desensitization protocol with co-trimoxazole. After 10 days, the patient could receive 800 mg of sulfamethoxazole and 160 mg of trimethoprim twice a day and no adverse reactions were observed. We suggest that desensitization protocols with co-trimoxazole be considered in patients with fixed drug eruption, especially when there are no alternative drugs.

Key words: Fixed drug eruption. Nonallergic drug hypersensitivity. Co-trimoxazole. Oral desensitization